BOSTON SCIENTIFIC CORPORATION Gain (Loss) on Investments
BOSTON SCIENTIFIC CORPORATION (BSX) reported Gain (Loss) on Investments of $146.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnInvestments · last filed 2026-08-03
- BOSTON SCIENTIFIC CORPORATION gain (loss) on investments for the quarter ending 2026-06-30 was -$12.00M, a 105.48% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION gain (loss) on investments for the quarter ending 2026-03-31 was $158.00M.
- BOSTON SCIENTIFIC CORPORATION gain (loss) on investments for the quarter ending 2025-12-31 was -$42.00M.
- BOSTON SCIENTIFIC CORPORATION gain (loss) on investments for the quarter ending 2025-09-30 was -$10.00M.
- BOSTON SCIENTIFIC CORPORATION gain (loss) on investments for fiscal 2025 was $139.00M.
- BOSTON SCIENTIFIC CORPORATION gain (loss) on investments for fiscal 2024 was -$79.00M.
- BOSTON SCIENTIFIC CORPORATION gain (loss) on investments for fiscal 2023 was -$59.00M.
- BOSTON SCIENTIFIC CORPORATION gain (loss) on investments for fiscal 2022 was -$1.00M, a 100.40% decline from fiscal 2021.
| Period end | Gain (Loss) on Investments 3 month | Gain (Loss) on Investments 6 month | Gain (Loss) on Investments 9 month | Gain (Loss) on Investments 12 month | Gain (Loss) on Investments 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$12.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $146.00M 10-Q · filed 2026-08-03 | $104.00M derived: sum of 3 quarters · filed 2026-08-03 | $94.00M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2026-03-31 | $158.00M 10-Q · filed 2026-05-01 | $116.00M derived: sum of 2 quarters · filed 2026-05-01 | $106.00M derived: sum of 3 quarters · filed 2026-05-01 | $325.00M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2025-12-31 | -$42.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$52.00M derived: sum of 2 quarters · filed 2026-02-17 | $167.00M derived: sum of 3 quarters · filed 2026-08-03 | $139.00M 10-K · filed 2026-02-17 | |
| 2025-09-30 | -$10.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $209.00M derived: sum of 2 quarters · filed 2026-08-03 | $181.00M 10-Q · filed 2025-11-03 | $162.00M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2025-06-30 | $219.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $191.00M 10-Q · filed 2026-08-03 | $172.00M derived: sum of 3 quarters · filed 2026-08-03 | $158.00M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2025-03-31 | -$28.00M 10-Q · filed 2026-05-01 | -$47.00M derived: sum of 2 quarters · filed 2026-05-01 | -$61.00M derived: sum of 3 quarters · filed 2026-05-01 | -$105.00M derived: sum of 4 quarters · filed 2026-05-01 | |
| 2024-12-31 | -$19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$33.00M derived: sum of 2 quarters · filed 2026-02-17 | -$77.00M derived: sum of 3 quarters · filed 2026-02-17 | -$79.00M 10-K · filed 2026-02-17 | |
| 2024-09-30 | -$14.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$58.00M derived: sum of 2 quarters · filed 2025-11-03 | -$60.00M 10-Q · filed 2025-11-03 | -$71.00M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-06-30 | -$44.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | -$46.00M 10-Q · filed 2025-08-01 | -$57.00M derived: sum of 3 quarters · filed 2026-02-17 | -$70.00M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-03-31 | -$2.00M 10-Q · filed 2025-05-01 | -$13.00M derived: sum of 2 quarters · filed 2026-02-17 | -$26.00M derived: sum of 3 quarters · filed 2026-02-17 | -$30.00M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2023-12-31 | -$11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$24.00M derived: sum of 2 quarters · filed 2026-02-17 | -$28.00M derived: sum of 3 quarters · filed 2026-02-17 | -$59.00M 10-K · filed 2026-02-17 | |
| 2023-09-30 | -$13.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | -$17.00M derived: sum of 2 quarters · filed 2024-11-01 | -$48.00M 10-Q · filed 2024-11-01 | -$3.00M derived: sum of 4 quarters · filed 2025-02-18 | |
| 2023-06-30 | -$4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$35.00M 10-Q · filed 2024-08-01 | $10.00M derived: sum of 3 quarters · filed 2025-02-18 | $0.00 derived: sum of 4 quarters · filed 2025-02-18 | |
| 2023-03-31 | -$31.00M 10-Q · filed 2024-05-01 | $14.00M derived: sum of 2 quarters · filed 2025-02-18 | $4.00M derived: sum of 3 quarters · filed 2025-02-18 | -$12.00M derived: sum of 4 quarters · filed 2025-02-18 | |
| 2022-12-31 | $45.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $35.00M derived: sum of 2 quarters · filed 2025-02-18 | $19.00M derived: sum of 3 quarters · filed 2025-02-18 | -$1.00M 10-K · filed 2025-02-18 | |
| 2022-09-30 | -$10.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$26.00M derived: sum of 2 quarters · filed 2023-11-01 | -$46.00M 10-Q · filed 2023-11-01 | -$4.00M derived: sum of 4 quarters · filed 2024-02-20 | |
| 2022-06-30 | -$16.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$36.00M 10-Q · filed 2023-08-03 | $6.00M derived: sum of 3 quarters · filed 2024-02-20 | $192.00M derived: sum of 4 quarters · filed 2024-02-20 | |
| 2022-03-31 | -$20.00M 10-Q · filed 2023-05-04 | $22.00M derived: sum of 2 quarters · filed 2024-02-20 | $208.00M derived: sum of 3 quarters · filed 2024-02-20 | $193.00M derived: sum of 4 quarters · filed 2024-02-20 | |
| 2021-12-31 | $42.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $228.00M derived: sum of 2 quarters · filed 2024-02-20 | $213.00M derived: sum of 3 quarters · filed 2024-02-20 | $250.00M 10-K · filed 2024-02-20 | |
| 2021-09-30 | $186.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $171.00M derived: sum of 2 quarters · filed 2022-11-03 | $208.00M 10-Q · filed 2022-11-03 | $512.00M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-06-30 | -$15.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $22.00M 10-Q · filed 2022-08-04 | $326.00M derived: sum of 3 quarters · filed 2023-02-23 | $389.00M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-03-31 | $37.00M 10-Q · filed 2022-05-05 | $341.00M derived: sum of 2 quarters · filed 2023-02-23 | $404.00M derived: sum of 3 quarters · filed 2023-02-23 | $392.00M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2020-12-31 | $304.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $367.00M derived: sum of 2 quarters · filed 2023-02-23 | $355.00M derived: sum of 3 quarters · filed 2023-02-23 | $333.00M 10-K · filed 2023-02-23 | $398.00M 10-K · filed 2021-02-23 |
| 2020-09-30 | $63.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $51.00M derived: sum of 2 quarters · filed 2021-11-04 | $29.00M 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | -$12.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$34.00M 10-Q · filed 2021-08-06 | |||
| 2020-03-31 | -$22.00M 10-Q · filed 2021-05-06 | ||||
| 2019-12-31 | -$30.00M 10-K · filed 2022-02-23 | ||||
| 2018-12-31 | $155.00M 10-K · filed 2021-02-23 | ||||
| 2017-12-31 | -$92.00M 10-K · filed 2020-02-25 | ||||
| 2016-12-31 | -$21.00M 10-K · filed 2019-02-19 | ||||
| 2015-12-31 | -$9.00M 10-K · filed 2018-02-20 | ||||
| 2014-12-31 | $27.00M 10-K · filed 2017-02-23 | ||||
| 2013-12-31 | -$9.00M 10-K · filed 2016-02-24 | ||||
| 2012-12-31 | $37.00M 10-K · filed 2015-02-25 | ||||
| 2011-12-31 | $27.00M 10-K · filed 2014-02-26 | ||||
| 2010-12-31 | -$12.00M 8-K · filed 2013-05-29 | $4.00M 10-K · filed 2011-02-17 | |||
| 2009-12-31 | $9.00M 10-K · filed 2012-02-17 | $23.00M 10-K · filed 2011-02-17 | |||
| 2008-12-31 | $52.00M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |